Evidence map›Paper›PMID 26308982›Full record

ReviewNature neuroscience2015

Optogenetics: 10 years of microbial opsins in neuroscience.

Karl Deisseroth

Abstract readReview
In one paragraph

Review in Nature neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 588 papers.

0numbers the graph read from it
0cells of the map it votes in
588citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

588 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Dilating the aging clock with light.Innovation (Cambridge (Mass.)) · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Over 1.65 GW cmLight, science & applications · 2026
    Article
  19. Control of cortical population activity with patterned microstimulation.bioRxiv : the preprint server for biology · 2026
    Article
  20. Review

528 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Karl DeisserothDepartments of Bioengineering and of Psychiatry and Behavioral Sciences and the Howard Hughes Medical Institute, Stanford University, Stanford, California, USA.

Funding

Structural and molecular identification of circuitry underlying joint processing of motivation and aversionR37DA035377 · NIDA · STANFORD UNIVERSITY · PI DEISSEROTH, KARL A. · 2013 to 2022
$6.2M
Technology development for fast optical interrogation of living neural circuitryR01MH075957 · NIMH · STANFORD UNIVERSITY · PI DEISSEROTH, KARL A. · 2008 to 2012
$2.6M
Howard Hughes Medical InstituteNIDA NIH HHS R37 DA035377NIMH NIH HHS R01 MH075957
6 · The paper itself

Abstract

Over the past 10 years, the development and convergence of microbial opsin engineering, modular genetic methods for cell-type targeting and optical strategies for guiding light through tissue have enabled versatile optical control of defined cells in living systems, defining modern optogenetics. Despite widespread recognition of the importance of spatiotemporally precise causal control over cellular signaling, for nearly the first half (2005-2009) of this 10-year period, as optogenetics was being created, there were difficulties in implementation, few publications and limited biological findings. In contrast, the ensuing years have witnessed a substantial acceleration in the application domain, with the publication of thousands of discoveries and insights into the function of nervous systems and beyond. This Historical Commentary reflects on the scientific landscape of this decade-long transition.

Indexed as

LightAnimalsBacteriorhodopsinsHumansNeurosciencesOpsinsOptogeneticsPhotic StimulationProtein Structure, SecondaryRhodopsins, MicrobialBacteriorhodopsinsOpsinsRhodopsins, Microbial

Identifiers

PMID26308982
PMCPMC4790845

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.